-+ 0.00%
-+ 0.00%
-+ 0.00%

SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY

Barchart·10/15/2026 09:15:00
Listen to the news

Unicycive's annual report warned only that the FDA "could ask us to supplement our submissions," while a securities class action alleges the Company never disclosed that it had not inspected the third-party manufacturer whose unresolved cGMP deficiencies triggered a second Complete Response Letter and a 39.1% single-day loss for UNCY shareholders.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.